Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Arrhythmias

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 374 articles: HTML format

Single Articles

July 2024
1. KANY S, Jurgens SJ, Ramo JT, Christophersen IE, et al
   Genetic testing in early-onset atrial fibrillation.
   Eur Heart J. 2024 Jul 19:ehae298. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. LANDMESSER U, Skurk C, Tzikas A, Falk V, et al
   Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives.
   Eur Heart J. 2024 Jul 19:ehae398. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. ANDREOTTI F, De Caterina R
   Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
   Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
   PubMed    
   
   
   
4. KAJIHARA Y
   Edoxaban-induced oesophagitis.
   Eur Heart J. 2024;45:2460.
   PubMed    
   
   
   
5. CHOI YJ, Lim J, Bea S, Lee J, et al
   Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study.
   Eur Heart J. 2024 Jul 12:ehae335. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. CONNORS JM
   Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarm.
   Eur Heart J. 2024 Jul 12:ehae336. doi: 10.1093.
   PubMed    
   
   
   
7. WILDE AAM, van der Werf C
   Risk scores in congenital long QT syndrome: friend or foe?
   Eur Heart J. 2024 Jul 10:ehae408. doi: 10.1093.
   PubMed    
   
   
   
8. CREA F
   A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
   Eur Heart J. 2024;45:2267-2270.
   PubMed    
   
   
   
9. BEHR ER
   Brugada syndrome: can polygenic risk scores help the clinician?
   Eur Heart J. 2024;45:2333-2335.
   PubMed    
   
   
   
10. SCACCIAVILLANI R
    Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
    Eur Heart J. 2024;45:2263.
    PubMed    
    
    
    
11. SAVASTANO S, Baldi E, Rordorf R
    Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm.
    Eur Heart J. 2024;45:2264.
    PubMed    
    
    
    
12. ISHIKAWA T, Masuda T, Hachiya T, Dina C, et al
    Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci.
    Eur Heart J. 2024;45:2320-2332.
    PubMed     Abstract available
    
    
    
13. AIRAKSINEN KEJ, De Sensi F
    Ten years of direct oral anticoagulants: lessons learned and challenges ahead.
    Eur Heart J. 2024;45:2178-2180.
    PubMed    
    
    
    
14. MURARU D, Badano LP
    Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
    Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
    PubMed    
    
    
    
15. LV L
    What influences the bleeding risk of long-term anticoagulation after catheter ablation in patients with atrial fibrillation at high risk of thromboembolism?
    Eur Heart J. 2024 Jul 2:ehae388. doi: 10.1093.
    PubMed    
    
    
    
16. KANAOKA K, Iwanaga Y
    Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk group.
    Eur Heart J. 2024 Jul 2:ehae389. doi: 10.1093.
    PubMed    
    
    
    
17. BECHER N, Metzner A, Toennis T, Kirchhof P, et al
    Atrial fibrillation burden: a new outcome predictor and therapeutic target.
    Eur Heart J. 2024 Jul 2:ehae373. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al
    Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm.
    Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
19. CREA F
    A focus on three hot topics: atrial fibrillation, obesity, and climate change.
    Eur Heart J. 2024;45:2105-2108.
    PubMed    
    
    
    
20. SANDERS P, Svennberg E, Diederichsen SZ, Crijns HJGM, et al
    Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation.
    Eur Heart J. 2024 Jun 27:ehae365. doi: 10.1093.
    PubMed    
    
    
    
21. SAMUEL M, Rienstra M, Van Gelder IC
    Ablation of persistent atrial fibrillation: never say never again.
    Eur Heart J. 2024 Jun 18:ehae374. doi: 10.1093.
    PubMed    
    
    
    
22. KHAIRY P
    A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot.
    Eur Heart J. 2024;45:2095-2097.
    PubMed    
    
    
    
23. KIMURA Y, Wallet J, Bouyer B, Jongbloed MRM, et al
    Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot.
    Eur Heart J. 2024;45:2079-2094.
    PubMed     Abstract available
    
    
    
24. STEINBERG BA
    Atrial fibrillation and long-term cardiovascular outcomes: bringing the whole picture into focus.
    Eur Heart J. 2024 Jun 7:ehae347. doi: 10.1093.
    PubMed    
    
    
    
25. FARMAKIS D, Filippatos G
    Cancer begets atrial fibrillation ... and vice versa?
    Eur Heart J. 2024 Jun 7:ehae301. doi: 10.1093.
    PubMed    
    
    
    
26. JOHNSON LS, Jiang Y, Luu J, Van Gelder IC, et al
    Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
    Eur Heart J. 2024 Jun 4:ehae319. doi: 10.1093.
    PubMed    
    
    
    May 2024
27. WANG J, Chen X, Zhao S
    Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy.
    Eur Heart J. 2024 May 31:ehae312. doi: 10.1093.
    PubMed    
    
    
    
28. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
    Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
    Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. NAGAE H, Kayawake H, Taniguchi T
    Chest tube-related complete atrioventricular block.
    Eur Heart J. 2024 May 28:ehae315. doi: 10.1093.
    PubMed    
    
    
    
30. BRIEGER D, Freedman B
    Taking the sex out of atrial fibrillation.
    Eur Heart J. 2024 May 24:ehae256. doi: 10.1093.
    PubMed    
    
    
    
31. CHAUHAN A, Banerjee A
    Atrial fibrillation and flutter: reiterating the need to 'Go hard, Go early'.
    Eur Heart J. 2024 May 23:ehae029. doi: 10.1093.
    PubMed    
    
    
    
32. CRIJNS HJGM, Lambiase PD, Sanders P
    The year in cardiovascular medicine 2023: the top 10 papers in arrhythmias.
    Eur Heart J. 2024;45:1730-1732.
    PubMed    
    
    
    
33. CROWLEY R, Chieng D, Sugumar H, Ling LH, et al
    Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilisation.
    Eur Heart J. 2024 May 17:ehae291. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. DUSI V, Dagradi F, Spazzolini C, Crotti L, et al
    Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.
    Eur Heart J. 2024 May 16:ehae289. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
    Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
    Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. ZEPPENFELD K, de Riva M
    Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
    Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
    PubMed    
    
    
    
37. VANDERSICKEL N, Hendrickx S, Van den Abeele R, Verstraeten B, et al
    Impact of topology on the number of loops during macro-re-entrant atrial tachycardia.
    Eur Heart J. 2024;45:1586-1588.
    PubMed    
    
    
    
38. TAN Y, Tao Y, Wang Z
    Isolated right-sided pericardial effusion following hybrid ablation for long-standing atrial fibrillation.
    Eur Heart J. 2024 May 4:ehae210. doi: 10.1093.
    PubMed    
    
    
    April 2024
39. NGO LTH, Peng Y, Denman R, Yang I, et al
    Long-term outcomes after hospitalization for atrial fibrillation or flutter.
    Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. LI YP, Chen JY
    Rapid onset of takotsubo cardiomyopathy induced by left bundle branch area pacing.
    Eur Heart J. 2024;45:1487.
    PubMed    
    
    
    
41. 
    Correction to: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
    Eur Heart J. 2024 Apr 17:ehae227. doi: 10.1093.
    PubMed    
    
    
    
42. CHEN Q, van Rein N, van der Hulle T, Heemelaar JC, et al
    Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study.
    Eur Heart J. 2024 Apr 15:ehae222. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. TEPPO K, Airaksinen KEJ, Jaakkola J, Halminen O, et al
    Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.
    Eur Heart J. 2024 Apr 12:ehae198. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. PALUDAN-MULLER C, Vad OB, Stampe NK, Diederichsen SZ, et al
    Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality.
    Eur Heart J. 2024 Apr 9:ehae216. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. LIP GYH, Nikorowitsch J, Sehner S, Becher N, et al
    Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.
    Eur Heart J. 2024 Apr 9:ehae225. doi: 10.1093.
    PubMed    
    
    
    
46. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    PubMed    
    
    
    
47. GAITA F, Cerrato N, Giustetto C
    Can an implantable loop recorder improve risk stratification and appropriate management in Brugada syndrome?
    Eur Heart J. 2024;45:1266-1268.
    PubMed    
    
    
    
48. BERGONTI M, Sacher F, Arbelo E, Crotti L, et al
    Implantable loop recorders in patients with Brugada syndrome: the BruLoop study.
    Eur Heart J. 2024;45:1255-1265.
    PubMed     Abstract available
    
    
    
49. EL-CHAMI MF, Garweg C, Clementy N, Al-Samadi F, et al
    Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.
    Eur Heart J. 2024;45:1241-1251.
    PubMed     Abstract available
    
    
    
50. LIUZZO G, Pedicino D
    Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation.
    Eur Heart J. 2024 Apr 1:ehae138. doi: 10.1093.
    PubMed    
    
    
    March 2024
51. CREA F
    Challenges in arrhythmias: anticoagulation in asymptomatic atrial fibrillation, stellate ganglion block in electrical storm, and ECG for prediction of sudden death.
    Eur Heart J. 2024;45:739-743.
    PubMed    
    
    
    
52. ZURIAGA MA, Pascual-Figal D, Fuster JJ
    Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations.
    Eur Heart J. 2024;45:806-808.
    PubMed    
    
    
    
53. SAVASTANO S, Baldi E, Compagnoni S, Rordorf R, et al
    Electrical storm treatment by percutaneous stellate ganglion block: the STAR study.
    Eur Heart J. 2024;45:823-833.
    PubMed     Abstract available
    
    
    
54. FIALHO GL
    Epilepsy and the heart: can 'brain arrhythmia' lead to cardiac arrhythmias? Back to the basics.
    Eur Heart J. 2024;45:853-854.
    PubMed    
    
    
    
55. PHAM HN, Holmstrom L, Chugh H, Uy-Evanado A, et al
    Dynamic electrocardiogram changes are a novel risk marker for sudden cardiac death.
    Eur Heart J. 2024;45:809-819.
    PubMed     Abstract available
    
    
    
56. SCHUERMANS A, Vlasschaert C, Nauffal V, Cho SMJ, et al
    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.
    Eur Heart J. 2024;45:791-805.
    PubMed     Abstract available
    
    
    
57. SUN Y, Zhou Y, Yu B, Zhang K, et al
    Frailty, genetic predisposition, and incident atrial fibrillation.
    Eur Heart J. 2024 Mar 5:ehae130. doi: 10.1093.
    PubMed    
    
    
    
58. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    PubMed    
    
    
    
59. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
60. SVENNBERG E, Diederichsen SZ
    Anticoagulation in device-detected atrial fibrillation: a long journey to find the sweet spot.
    Eur Heart J. 2024 Feb 21:ehae044. doi: 10.1093.
    PubMed    
    
    
    
61. CREA F
    Anticoagulation in atrial fibrillation and implantable cardioverter defibrillator implantation in arrhythmogenic right ventricular cardiomyopathy: need for improving patient selection.
    Eur Heart J. 2024;45:491-494.
    PubMed    
    
    
    
62. MALIK V, Shivkumar K
    Stellate ganglion blockade for the management of ventricular arrhythmia storm.
    Eur Heart J. 2024 Feb 15:ehae083. doi: 10.1093.
    PubMed    
    
    
    
63. HOLT A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al
    Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
    Eur Heart J. 2024;45:475-484.
    PubMed     Abstract available
    
    
    
64. ZURKAN D, Pitt B, Edelmann F
    Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?
    Eur Heart J. 2024 Feb 6:ehae040. doi: 10.1093.
    PubMed    
    
    
    
65. LIUZZO G, Patrono C
    Edoxaban for atrial high-rate episodes: more harm than good?
    Eur Heart J. 2024;45:330-331.
    PubMed    
    
    
    January 2024
66. ELLIOTT PM
    Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2024 Jan 30:ehae022. doi: 10.1093.
    PubMed    
    
    
    
67. YOUNES H, Rao S, Marrouche N
    Deciphering connections: how is cryoablation interlinking with disease progression in atrial fibrillation ablation?
    Eur Heart J. 2024 Jan 24:ehad872. doi: 10.1093.
    PubMed    
    
    
    
68. BRIENESSE S, Passman R, Freedman B
    Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification.
    Eur Heart J. 2024 Jan 23:ehad874. doi: 10.1093.
    PubMed    
    
    
    
69. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. VERGALLO R, Galiuto L
    Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
    Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
    PubMed    
    
    
    
71. AHN HJ, An HY, Ryu G, Lim J, et al
    Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
    Eur Heart J. 2024 Jan 17:ehad869. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. SAMARAS A, Papazoglou AS, Balomenakis C, Bekiaridou A, et al
    Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis.
    Eur Heart J. 2024;45:214-229.
    PubMed     Abstract available
    
    
    
73. ORAII A, Healey JS, Kowalik K, Pandey AK, et al
    Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials.
    Eur Heart J. 2024 Jan 9:ehad811. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. CARRICK RT, De Marco C, Gasperetti A, Bosman LP, et al
    Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
    Eur Heart J. 2024 Jan 9:ehad799. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. LIUZZO G, Patrono C
    Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation.
    Eur Heart J. 2024 Jan 8:ehad859. doi: 10.1093.
    PubMed    
    
    
    
76. CREA F
    The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation.
    Eur Heart J. 2024;45:1-4.
    PubMed    
    
    
    
77. PIESZKO K, Hiczkiewicz J, Lojewska K, Uzieblo-Zyczkowska B, et al
    Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.
    Eur Heart J. 2024;45:32-41.
    PubMed     Abstract available
    
    
    December 2023
78. PROVIDENCIA R, Kukendra-Rajah K, Barra S
    Amiodarone for atrial fibrillation: a dead man walking?
    Eur Heart J. 2023 Dec 29:ehad825. doi: 10.1093.
    PubMed    
    
    
    
79. KRAMARENKO D, Walsh R
    Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications.
    Eur Heart J. 2023;44:5074-5076.
    PubMed    
    
    
    
80. KANAOKA K, Nishida T, Iwanaga Y, Nakai M, et al
    Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
    Eur Heart J. 2023 Dec 20:ehad798. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. HATALA R, Hlivak P
    Atrial fibrillation in chronic coronary syndromes: a neglected challenge.
    Eur Heart J. 2023 Dec 17:ehad781. doi: 10.1093.
    PubMed    
    
    
    November 2023
82. SPOSATO LA, Lip GYH, Haeusler KG
    Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?
    Eur Heart J. 2023 Nov 28:ehad744. doi: 10.1093.
    PubMed    
    
    
    
83. ANJUM M, Ariansen I, Hjellvik V, Selmer R, et al
    Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
    Eur Heart J. 2023 Nov 23:ehad659. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. MARCHLINSKI FE, Oraii A, Muser D
    Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?
    Eur Heart J. 2023 Nov 23:ehad751. doi: 10.1093.
    PubMed    
    
    
    
85. BECHER N, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, et al
    Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes >/=24 hours.
    Eur Heart J. 2023 Nov 12:ehad771. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. TSABAN G, Ostrovsky D, Alnsasra H, Burrack N, et al
    Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study.
    Eur Heart J. 2023 Nov 6:ehad726. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    PubMed    
    
    
    
88. INCIARDI RM, Solomon SD
    Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure.
    Eur Heart J. 2023 Nov 3:ehad747. doi: 10.1093.
    PubMed    
    
    
    October 2023
89. ELLIOTT AD, Benjamin EJ, Middeldorp ME
    Prevention of atrial fibrillation: a call to action.
    Eur Heart J. 2023 Oct 31:ehad738. doi: 10.1093.
    PubMed    
    
    
    
90. TILZ RR, Heeger CH
    Be aware and hit hard and early: oesophageal lesions after atrial fibrillation ablation.
    Eur Heart J. 2023 Oct 26:ehad692. doi: 10.1093.
    PubMed    
    
    
    
91. SCANAVACCA M, Pisani C, Rivarola EWR
    Early identification of oesophageal lesions after atrial fibrillation ablation to prevent atrio-oesophageal fistula.
    Eur Heart J. 2023 Oct 26:ehad689. doi: 10.1093.
    PubMed    
    
    
    
92. CREA F
    Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction.
    Eur Heart J. 2023;44:4203-4207.
    PubMed    
    
    
    
93. PEDICINO D, Volpe M
    Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure: is it all gold the glitter in the CASTLE?
    Eur Heart J. 2023 Oct 17:ehad675. doi: 10.1093.
    PubMed    
    
    
    
94. MARX N, Federici M, Schutt K, Muller-Wieland D, et al
    2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
    Eur Heart J. 2023;44:4043-4140.
    PubMed    
    
    
    
95. APOSTOLOS A, Aggeli C, Toutouzas K
    Nickel hypersensitivity as the cause of atrial fibrillation after patent foramen ovale closure: fact or myth?
    Eur Heart J. 2023 Oct 4:ehad643. doi: 10.1093.
    PubMed    
    
    
    
96. PAPIOL E, Pastor P, Pueo E
    Skin lesions, weight loss, and ventricular tachycardia: connecting the dots to diagnose multisystemic sarcoidosis.
    Eur Heart J. 2023;44:3705.
    PubMed    
    
    
    September 2023
97. LI E, Yan C, Yang X
    Long QT syndrome induced by cervical spondylosis.
    Eur Heart J. 2023 Sep 22:ehad608. doi: 10.1093.
    PubMed    
    
    
    
98. CREA F
    Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation.
    Eur Heart J. 2023;44:3391-3394.
    PubMed    
    
    
    
99. TANAKA Y, Kuroki K, Kaga S
    Life-threatening left atrioesophageal fistula complicated with catheter ablation for atrial fibrillation in a patient with aortic stent graft.
    Eur Heart J. 2023 Sep 19:ehad609. doi: 10.1093.
    PubMed    
    
    
    
100. WANG N, Yu Y, Sun Y, Zhang H, et al
     Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition.
     Eur Heart J. 2023 Sep 19:ehad615. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. CREA F
     Focus on atrial fibrillation in specific clinical settings and on calmodulinopathy.
     Eur Heart J. 2023;44:3299-3302.
     PubMed    
     
     
     
102. WANG J, Huang P, Yu Q, Lu J, et al
     Epilepsy and long-term risk of arrhythmias.
     Eur Heart J. 2023;44:3374-3382.
     PubMed     Abstract available
     
     
     
103. BARSHESHET A, Goldenberg I
     Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromes.
     Eur Heart J. 2023;44:3371-3373.
     PubMed    
     
     
     
104. CROTTI L, Spazzolini C, Nyegaard M, Overgaard MT, et al
     Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry.
     Eur Heart J. 2023;44:3357-3370.
     PubMed     Abstract available
     
     
     
105. MOHANTY S, La Fazia VM, Natale A
     The Antwerp score: is this the 'new hope on the horizon'?
     Eur Heart J. 2023;44:3336-3338.
     PubMed    
     
     
     
106. GONG X, Liu JX, Huang XB
     Surgical removal of acoustic neuroma eliminates sick sinus syndrome.
     Eur Heart J. 2023;44:3388.
     PubMed    
     
     
     
107. COURT-KOWALSKI S, McArthur A, Hayres K
     Pulsus paradoxus, electrical alternans, and pulsus alternans in progressive cardiac tamponade.
     Eur Heart J. 2023;44:3297.
     PubMed    
     
     
     
108. MIDDELDORP ME, Sandhu RK
     The stroke enigma: decoding the sex risk factor in atrial fibrillation.
     Eur Heart J. 2023 Sep 6:ehad531. doi: 10.1093.
     PubMed    
     
     
     August 2023
109. BUHARI H, Fang J, Han L, Austin PC, et al
     Stroke risk in women with atrial fibrillation.
     Eur Heart J. 2023 Aug 30:ehad508. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. CANNIE DE, Syrris P, Protonotarios A, Bakalakos A, et al
     Emery-Dreifuss Muscular Dystrophy 1 is associated with high risk of malignant ventricular arrhythmias and end-stage heart failure.
     Eur Heart J. 2023 Aug 28:ehad561. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. NASER JA, Lee E, Scott CG, Kennedy AM, et al
     Prevalence and Incidence of Diastolic Dysfunction in Atrial Fibrillation: Clinical Implications.
     Eur Heart J. 2023 Aug 28:ehad592. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. PARKASH R
     Atrial pacing and atrial fibrillation in sinus node dysfunction: a relationship that remains elusive.
     Eur Heart J. 2023 Aug 28:ehad569. doi: 10.1093.
     PubMed    
     
     
     
113. KRONBORG MB, Frausing MHJP, Malczynski J, Riahi S, et al
     Atrial pacing minimization in sinus node dysfunction and risk of incident atrial fibrillation: a randomized trial.
     Eur Heart J. 2023 Aug 28:ehad564. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. GAUTIER A, Picard F, Ducrocq G, Elbez Y, et al
     New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry.
     Eur Heart J. 2023 Aug 27:ehad556. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. ANDRADE JG, Deyell MW, Khairy P, Champagne J, et al
     Atrial fibrillation progression after cryoablation versus radiofrequency ablation: the CIRCA-DOSE trial.
     Eur Heart J. 2023 Aug 25:ehad572. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. MEYRE PB, Conen D
     Adverse outcomes in patients with atrial fibrillation: how previous successes can unmask new challenges.
     Eur Heart J. 2023 Aug 25:ehad575. doi: 10.1093.
     PubMed    
     
     
     
117. WU J, Nadarajah R, Nakao YM, Nakao K, et al
     Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation.
     Eur Heart J. 2023 Aug 25:ehad571. doi: 10.1093.
     PubMed     Abstract available
     
     
     
118. VERRIER RL, Pang TD, Schachter SC
     Long-term risk for atrial and ventricular arrhythmias: a cardinal manifestation of 'the epileptic heart'.
     Eur Heart J. 2023 Aug 22:ehad524. doi: 10.1093.
     PubMed    
     
     
     
119. KAWAKAMI R, Finn AV, Virmani R
     Histopathology of atrial fibrillation: does this help us understand its pathogenesis?
     Eur Heart J. 2023 Aug 17:ehad515. doi: 10.1093.
     PubMed    
     
     
     
120. OZKAN J
     Barbara Casadei receives award for outstanding research into atrial fibrillation.
     Eur Heart J. 2023 Aug 16:ehad495. doi: 10.1093.
     PubMed    
     
     
     
121. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
     Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
     Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2023
122. CAMM AJ
     Should the risk of atrial fibrillation deter PFO closure for cryptogenic ischaemic stroke?
     Eur Heart J. 2023 Jul 21:ehad425. doi: 10.1093.
     PubMed    
     
     
     
123. CREA F
     Addressing the pandemic of atrial fibrillation: optimization of catheter ablation and new therapeutic targets.
     Eur Heart J. 2023;44:2413-2416.
     PubMed    
     
     
     
124. WILDE AAM, Amin AS, Morita H, Tadros R, et al
     Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome.
     Eur Heart J. 2023;44:2427-2439.
     PubMed     Abstract available
     
     
     
125. SUDO K, Kuroki K, Sato A
     Dynamical improvement after rescue balloon angioplasty for pulmonary vein occlusion complicated with radiofrequency catheter ablation.
     Eur Heart J. 2023;44:2498.
     PubMed    
     
     
     
126. MARCUS GM
     Translating HARMS2-AF into benefits for our atrial fibrillation patients and the general public: challenges and opportunities.
     Eur Heart J. 2023 Jul 5:ehad423. doi: 10.1093.
     PubMed    
     
     
     
127. PEDICINO D, Volpe M
     Coffee drinking and cardiac ectopic beats: Black or White?
     Eur Heart J. 2023;44:2275-2276.
     PubMed    
     
     
     June 2023
128. BERGONTI M, Ascione C, Marcon L, Pambrun T, et al
     Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure: a prediction model.
     Eur Heart J. 2023 Jun 30:ehad428. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. DOUGHERTY S, Nascimento B, Okello E
     Oral anticoagulation for atrial fibrillation in rheumatic heart disease.
     Eur Heart J. 2023 Jun 29:ehad390. doi: 10.1093.
     PubMed    
     
     
     
130. TAKAHASHI Y, Yamaguchi T, Otsubo T, Nakashima K, et al
     Histological validation of atrial structural remodelling in patients with atrial fibrillation.
     Eur Heart J. 2023 Jun 23:ehad396. doi: 10.1093.
     PubMed     Abstract available
     
     
     
131. SEGAN L, Canovas R, Nanayakkara S, Chieng D, et al
     New-onset atrial fibrillation prediction: the HARMS2-AF risk score.
     Eur Heart J. 2023 Jun 23:ehad375. doi: 10.1093.
     PubMed     Abstract available
     
     
     
132. METZNER A, Kirchhof P
     Good rhythm control without haste: atrial fibrillation ablation remains effective after a year of waiting.
     Eur Heart J. 2023 Jun 22:ehad393. doi: 10.1093.
     PubMed    
     
     
     
133. LIM MW, Kalman JM
     Putting fear into perspective: estimating the true incidence of oesophageal fistula formation post-atrial fibrillation ablation.
     Eur Heart J. 2023 Jun 8:ehad309. doi: 10.1093.
     PubMed    
     
     
     
134. SKIBSTED CV, Korsholm K, Pedersen L, Bonnesen K, et al
     Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study.
     Eur Heart J. 2023 Jun 3:ehad305. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2023
135. LEHTONEN J, Uusitalo V, Poyhonen P, Mayranpaa MI, et al
     Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis.
     Eur Heart J. 2023;44:1495-1510.
     PubMed     Abstract available
     
     
     April 2023
136. LEE J, Kim JS, Shim CY
     MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
     Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
     PubMed    
     
     
     
137. TILZ RR, Schmidt V, Purerfellner H, Maury P, et al
     A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study.
     Eur Heart J. 2023 Apr 16:ehad250. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. KALMAN JM, Al-Kaisey AM, Parameswaran R, Hawson J, et al
     Impact of Early Versus Delayed Atrial Fibrillation Catheter Ablation on Atrial Arrhythmia Recurrences.
     Eur Heart J. 2023 Apr 16:ehad247. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. HAEUSLER KG
     Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation-a call for A-C-T-I-O-N.
     Eur Heart J. 2023 Apr 11:ehad203. doi: 10.1093.
     PubMed    
     
     
     
140. BENZ AP, Hohnloser SH, Eikelboom JW, Carnicelli AP, et al
     Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
     Eur Heart J. 2023 Apr 11:ehad200. doi: 10.1093.
     PubMed     Abstract available
     
     
     
141. RENNISON JH, Van Wagoner DR
     Dysregulated Ca2+ cycling in atrial fibrillation.
     Eur Heart J. 2023 Apr 4:ehad099. doi: 10.1093.
     PubMed    
     
     
     March 2023
142. FRIMODT-MOLLER EK, Soliman EZ, Kizer JR, Vittinghoff E, et al
     Lifestyle habits associated with cardiac conduction disease.
     Eur Heart J. 2023;44:1058-1066.
     PubMed     Abstract available
     
     
     
143. NOUBIAP JJ, Middeldorp ME
     Prevention of cardiac conduction disease: a long way to go.
     Eur Heart J. 2023;44:1067-1069.
     PubMed    
     
     
     
144. THIELE H, Desch S, Freund A
     Out-of-hospital cardiac arrest without ST-segment elevation: an alternative focus on priorities?
     Eur Heart J. 2023;44:1055-1057.
     PubMed    
     
     
     
145. CREA F
     Cardiovascular diseases in pregnancy, congenital heart disease, and arrhythmias: lessons from epidemiology.
     Eur Heart J. 2023;44:699-702.
     PubMed    
     
     
     
146. AL-KAISEY AM, Kalman JM
     Atrial arrhythmia recurrence post-catheter ablation: when perfect is the enemy of good.
     Eur Heart J. 2023;44:777-779.
     PubMed    
     
     
     February 2023
147. GRAMMATIKA PAVLIDOU N, Dobrev S, Beneke K, Reinhardt F, et al
     Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism.
     Eur Heart J. 2023 Feb 22:ehad086. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. LIU X, Luo H, Qin X
     Vanishing 'table tennis': a case of active left atrial thrombus.
     Eur Heart J. 2023;44:698.
     PubMed    
     
     
     
149. WOUTERS PC, van de Leur RR, Vessies MB, van Stipdonk AMW, et al
     Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy.
     Eur Heart J. 2023;44:680-692.
     PubMed     Abstract available
     
     
     
150. LAMBIASE PD, Sanders P, Crijns HJGM
     The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias.
     Eur Heart J. 2023;44:345-347.
     PubMed    
     
     
     January 2023
151. GAUDINO M, Di Franco A, Rong LQ, Piccini J, et al
     Postoperative atrial fibrillation: from mechanisms to treatment.
     Eur Heart J. 2023 Jan 31:ehad019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
152. BUTCHER SC, Essayagh B, Steyerberg EW, Benfari G, et al
     Factors influencing post-surgical survival in degenerative mitral regurgitation.
     Eur Heart J. 2023 Jan 26:ehad004. doi: 10.1093.
     PubMed     Abstract available
     
     
     
153. 
     Corrigendum to: Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
     Eur Heart J. 2023 Jan 24:ehad045. doi: 10.1093.
     PubMed    
     
     
     
154. KANAMURA T, Hashimoto T, Shiose A, Tsutsui H, et al
     Thrombus associated with locked-in atrial fibrillation in recipient remnant left atrium after heart transplantation.
     Eur Heart J. 2023 Jan 20:ehad008. doi: 10.1093.
     PubMed    
     
     
     
155. NARDUCCI ML, Pedicino D
     A new defibrillation strategy for refractory ventricular fibrillation during out-of-hospital cardiac arrest: are two better than one?
     Eur Heart J. 2023 Jan 20:ehad002. doi: 10.1093.
     PubMed    
     
     
     
156. WALDMANN V, Barra S, Marijon E
     Ventricular arrhythmias and sudden cardiac death in heart failure with mildly reduced or preserved ejection fraction: knowledge gaps.
     Eur Heart J. 2023 Jan 20:ehad001. doi: 10.1093.
     PubMed    
     
     
     
157. CREA F
     Management of atrial fibrillation: role of population screening, biomarkers, and polygenic risk scores.
     Eur Heart J. 2023;44:167-170.
     PubMed    
     
     
     
158. CURTAIN JP, Adamson C, Kondo T, Butt J, et al
     Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
     Eur Heart J. 2023 Jan 12:ehac801. doi: 10.1093.
     PubMed     Abstract available
     
     
     
159. ACHA MR, Glikson M
     Type 2 diabetes mellitus association with atrioventricular block.
     Eur Heart J. 2023 Jan 7:ehac755. doi: 10.1093.
     PubMed    
     
     
     December 2022
160. LIUZZO G, Patrono C
     Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation.
     Eur Heart J. 2022 Dec 17:ehac721. doi: 10.1093.
     PubMed    
     
     
     
161. MATUSIK PS, Matusik PT, Stein PK
     Heart rate variability and heart rate patterns measured from wearable and implanted devices in screening for atrial fibrillation: potential clinical and population-wide applications.
     Eur Heart J. 2022 Dec 17:ehac546. doi: 10.1093.
     PubMed    
     
     
     
162. CREA F
     Novel risk factors for atrial fibrillation, conduction disturbances, sudden coronary death, and device infection.
     Eur Heart J. 2022;43:4853-4857.
     PubMed    
     
     
     
163. LAZZERINI PE, Boutjdir M, Capecchi PL
     Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the 'dark side of the immune'.
     Eur Heart J. 2022;43:4920-4922.
     PubMed    
     
     
     
164. AKUKA A, Ben-Shabat N, Watad A, Tsur AM, et al
     Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances.
     Eur Heart J. 2022;43:4912-4919.
     PubMed     Abstract available
     
     
     
165. TFELT-HANSEN J, Winkel BG, de Riva M, Zeppenfeld K, et al
     The '10 commandments' for the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
     Eur Heart J. 2022 Dec 7:ehac699. doi: 10.1093.
     PubMed    
     
     
     
166. O'SULLIVAN JW, Ashley EA, Elliott PM
     Polygenic risk scores for the prediction of cardiometabolic disease.
     Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. ANDREOTTI F, Geisler T, Collet JP, Gigante B, et al
     Acute, periprocedural and longterm antithrombotic therapy in older adults.
     Eur Heart J. 2022 Dec 7:ehac515. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. ANDRADE JG, Deyell MW, Macle L, Steinberg JS, et al
     Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study.
     Eur Heart J. 2022 Dec 2:ehac692. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. SPATZ ES, Herrin J
     Screening for atrial fibrillation to prevent stroke: increasing enthusiasm but outcomes still lag.
     Eur Heart J. 2022 Dec 2:ehac696. doi: 10.1093.
     PubMed    
     
     
     
170. OSMANCIK P, Widimsky P
     Left atrial appendage occluders-new hope for stroke prevention in high-risk patients.
     Eur Heart J. 2022;43:4669-4671.
     PubMed    
     
     
     November 2022
171. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
     Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
     Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
     PubMed     Abstract available
     
     
     
172. KU L, Chen Y, Ma X
     Pericardial-esophageal fistula caused by radiofrequency ablation for atrial fibrillation.
     Eur Heart J. 2022 Nov 22:ehac673. doi: 10.1093.
     PubMed    
     
     
     
173. SINNER MF, von Falkenhausen AS
     A specific new biomarker for atrial fibrillation and its sequelae?
     Eur Heart J. 2022 Nov 18. pii: 6833208. doi: 10.1093.
     PubMed    
     
     
     
174. GOLDENBERG L, Huang DT
     Subcutaneous implantable cardioverter defibrillator for the prevention of sudden cardiac death: ready for prime-time?
     Eur Heart J. 2022 Nov 16. pii: 6830653. doi: 10.1093.
     PubMed    
     
     
     
175. HIJAZI Z, Benz AP, Lindback J, Alexander JH, et al
     Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
     Eur Heart J. 2022 Nov 16. pii: 6830621. doi: 10.1093.
     PubMed     Abstract available
     
     
     
176. HARRINGTON J, Granger CB
     Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem.
     Eur Heart J. 2022 Nov 16. pii: 6830575. doi: 10.1093.
     PubMed    
     
     
     
177. HOLMSTROM L, Chugh SS
     How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
     Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
     PubMed    
     
     
     
178. LYTH J, Svennberg E, Bernfort L, Aronsson M, et al
     Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.
     Eur Heart J. 2022 Nov 9. pii: 6806218. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2022
179. GARCIA R, Marijon E, Karam N, Narayanan K, et al
     Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
     Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
     PubMed     Abstract available
     
     
     
180. MEYRE PB, Blum S, Hennings E, Aeschbacher S, et al
     Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
     Eur Heart J. 2022 Oct 26. pii: 6773770. doi: 10.1093.
     PubMed     Abstract available
     
     
     
181. GAWALKO M, Sanders P
     Drug abuse and risk of atrial fibrillation: a neglected association.
     Eur Heart J. 2022 Oct 26. pii: 6774408. doi: 10.1093.
     PubMed    
     
     
     
182. YANG Y, Xie L, Qian H, Cui K, et al
     Minimally invasive videoscope-assisted cardiac surgery for paroxysmal atrial tachycardia originating from right atrial appendage.
     Eur Heart J. 2022 Oct 26. pii: 6774389. doi: 10.1093.
     PubMed    
     
     
     
183. KAAB S, Holm H, Kirchhof P
     Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure.
     Eur Heart J. 2022 Oct 21. pii: 6767860. doi: 10.1093.
     PubMed    
     
     
     
184. CREA F
     New tools to predict and new therapeutic targets to treat life-threatening ventricular arrhythmias.
     Eur Heart J. 2022;43:3983-3986.
     PubMed    
     
     
     
185. BRIGNOLE M, Sutton R
     Left bundle branch area pacing in perspective.
     Eur Heart J. 2022;43:4174-4176.
     PubMed    
     
     
     
186. LINZ D, McIntyre WF
     Sinus rhythm: the sine qua non for rhythm control?
     Eur Heart J. 2022;43:4145-4147.
     PubMed    
     
     
     
187. JASTRZEBSKI M, Kielbasa G, Cano O, Curila K, et al
     Left bundle branch area pacing outcomes: the multicentre European MELOS study.
     Eur Heart J. 2022;43:4161-4173.
     PubMed     Abstract available
     
     
     
188. VANDEWIELE F, Pironet A, Jacobs G, Kecskes M, et al
     TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.
     Eur Heart J. 2022;43:4195-4207.
     PubMed     Abstract available
     
     
     
189. HEIJMAN J, Dobrev D
     Molecular determinants and therapeutic potential of focal ectopic activity: more than meets the Iti.
     Eur Heart J. 2022;43:4208-4210.
     PubMed    
     
     
     
190. TORBATI T, Shufelt C, Wei J, Noel Bairey Merz C, et al
     Premature menopause and cardiovascular disease: can we blame estrogen?
     Eur Heart J. 2022;43:4158-4160.
     PubMed    
     
     
     
191. MONDA E, Lioncino M, Limongelli G
     Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: the challenge of complex statistical modelling and its impact in clinical practice.
     Eur Heart J. 2022 Oct 20. pii: 6763998. doi: 10.1093.
     PubMed    
     
     
     
192. CADRIN-TOURIGNY J, Bosman LP, James CA
     Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: a practical approach to navigating the challenges of prediction models.
     Eur Heart J. 2022 Oct 20. pii: 6764102. doi: 10.1093.
     PubMed    
     
     
     
193. LIN AL, Nah G, Tang JJ, Vittinghoff E, et al
     Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation.
     Eur Heart J. 2022 Oct 18. pii: 6754793. doi: 10.1093.
     PubMed     Abstract available
     
     
     
194. LI J
     Long QT syndrome: long story short.
     Eur Heart J. 2022 Oct 18. pii: 6762505. doi: 10.1093.
     PubMed    
     
     
     
195. XIAO Q, Pu X, Wei X, Chen M, et al
     Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
     Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
     PubMed    
     
     
     September 2022
196. NABETA T, Kitai T, Naruse Y, Taniguchi T, et al
     Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
     Eur Heart J. 2022;43:3450-3459.
     PubMed     Abstract available
     
     
     
197. MA S, Jiang J
     Pulmonary vein stenosis stenting in a patient with persistent left superior vena cava after atrial fibrillation ablation.
     Eur Heart J. 2022 Sep 16. pii: 6701795. doi: 10.1093.
     PubMed    
     
     
     
198. 
     Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
     Eur Heart J. 2022 Sep 15. pii: 6701590. doi: 10.1093.
     PubMed    
     
     
     
199. KOVACS B, Mayinger M, Andratschke N, Saguner AM, et al
     Stereotactic arrhythmia radioablation: competitor or adjunct to catheter ablation?
     Eur Heart J. 2022;43:3279-3281.
     PubMed    
     
     
     August 2022
200. SMEDSRUD MK, Chivulescu M, Forsa MI, Castrini I, et al
     Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
     Eur Heart J. 2022 Aug 29. pii: 6676380. doi: 10.1093.
     PubMed     Abstract available
     
     
     
201. ECKARDT L, Sehner S, Suling A, Borof K, et al
     Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST - AFNET 4 trial.
     Eur Heart J. 2022 Aug 29. pii: 6675568. doi: 10.1093.
     PubMed     Abstract available
     
     
     
202. KONDO T, Abdul-Rahim AH, Talebi A, Abraham WT, et al
     Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
     Eur Heart J. 2022 Aug 26. pii: 6676501. doi: 10.1093.
     PubMed     Abstract available
     
     
     
203. ZEPPENFELD K, Tfelt-Hansen J, de Riva M, Winkel BG, et al
     2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
     Eur Heart J. 2022 Aug 26. pii: 6675633. doi: 10.1093.
     PubMed    
     
     
     
204. SAGRIS D, Shantsila E, Lip GYH
     Stroke risk stratification in patients with heart failure and sinus rhythm.
     Eur Heart J. 2022 Aug 26. pii: 6676507. doi: 10.1093.
     PubMed    
     
     
     
205. CHEN Q, Sen B, Feng X, Yang Q, et al
     Catastrophic atrial tachycardia-induced cardiomyopathy in a teenager treated by extracorporeal membrane oxygenation and stereotactic arrhythmia radioablation.
     Eur Heart J. 2022;43:3086.
     PubMed    
     
     
     
206. CORRADO D, Link MS, Schwartz PJ
     Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?
     Eur Heart J. 2022;43:3029-3040.
     PubMed     Abstract available
     
     
     
207. GRONDIN S, Davies B, Cadrin-Tourigny J, Steinberg C, et al
     Importance of genetic testing in unexplained cardiac arrest.
     Eur Heart J. 2022;43:3071-3081.
     PubMed     Abstract available
     
     
     
208. HUQI A, Zoccali C, Giugliano RP, De Caterina R, et al
     Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?
     Eur Heart J. 2022 Aug 19. pii: 6671685. doi: 10.1093.
     PubMed    
     
     
     
209. MARSTON NA, Garfinkel AC, Kamanu FK, Melloni GM, et al
     A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
     Eur Heart J. 2022 Aug 18. pii: 6671409. doi: 10.1093.
     PubMed     Abstract available
     
     
     
210. NARDUCCI ML, Volpe M
     Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation.
     Eur Heart J. 2022 Aug 8. pii: 6658237. doi: 10.1093.
     PubMed    
     
     
     
211. 
     Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
     Eur Heart J. 2022 Aug 5. pii: 6656112. doi: 10.1093.
     PubMed    
     
     
     
212. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
     Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
     Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
     PubMed    
     
     
     
213. SHIN J, Han K, Jung JH, Park HJ, et al
     Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study.
     Eur Heart J. 2022 Aug 4. pii: 6646730. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2022
214. KHAIRY P
     Sudden cardiac death in adults with transposition of the great arteries and systemic right ventricles: preventing (night)MAREs.
     Eur Heart J. 2022;43:2695-2697.
     PubMed    
     
     
     
215. BRIDA M, Chessa M, Celermajer D, Li W, et al
     Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
     Eur Heart J. 2022;43:2660-2671.
     PubMed     Abstract available
     
     
     
216. 
     Corrigendum to: Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
     Eur Heart J. 2022 Jul 8. pii: 6633850. doi: 10.1093.
     PubMed    
     
     
     
217. LIP GYH, Lane DA, Lenarczyk R, Boriani G, et al
     Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
     Eur Heart J. 2022;43:2442-2460.
     PubMed     Abstract available
     
     
     June 2022
218. PROTONOTARIOS A, Bariani R, Cappelletto C, Pavlou M, et al
     Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
     Eur Heart J. 2022 Jun 29. pii: 6619317. doi: 10.1093.
     PubMed     Abstract available
     
     
     
219. JORDA P, Bosman LP, Gasperetti A, Mazzanti A, et al
     Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
     Eur Heart J. 2022 Jun 29. pii: 6619318. doi: 10.1093.
     PubMed     Abstract available
     
     
     
220. GANDJBAKHCH E, Vischer AS
     Arrhythmogenic right ventricular cardiomyopathy: the never-ending quest for a risk calculator.
     Eur Heart J. 2022 Jun 29. pii: 6619319. doi: 10.1093.
     PubMed    
     
     
     
221. GOYAL P, Kim M, Krishnan U, Mccullough SA, et al
     Post-operative atrial fibrillation and risk of heart failure hospitalization.
     Eur Heart J. 2022 Jun 28. pii: 6617280. doi: 10.1093.
     PubMed     Abstract available
     
     
     
222. MIDDELDORP ME, Albert CM
     Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery.
     Eur Heart J. 2022 Jun 28. pii: 6617281. doi: 10.1093.
     PubMed    
     
     
     
223. NINNI S, Longere B, Mirabel X
     Stereotactic radioablation to treat ventricular tachycardia related to a left ventricular mass.
     Eur Heart J. 2022;43:2341.
     PubMed    
     
     
     
224. 
     Erratum to: Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
     Eur Heart J. 2022 Jun 18. pii: 6610027. doi: 10.1093.
     PubMed    
     
     
     
225. WEI X, Zhou M, Chen Y, Chen M, et al
     Paroxysmal massive mitral regurgitation.
     Eur Heart J. 2022 Jun 17. pii: 6609956. doi: 10.1093.
     PubMed    
     
     
     
226. CREA F
     The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
     Eur Heart J. 2022;43:2165-2169.
     PubMed    
     
     
     
227. LADOUCEUR M, Van De Bruaene A, Kauling R, Budts W, et al
     A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle.
     Eur Heart J. 2022 Jun 8. pii: 6604048. doi: 10.1093.
     PubMed     Abstract available
     
     
     
228. CACHEUX M, Akar FG
     A novel exosome-based therapy for post-MI arrhythmias.
     Eur Heart J. 2022;43:2157-2159.
     PubMed    
     
     
     
229. BRIGNOLE M, Soranna D, Rienstra M
     Is APAF-CRT robust enough to change clinical practice?
     Eur Heart J. 2022;43:2161-2162.
     PubMed    
     
     
     
230. PABEL S, Sossalla S
     Atrial fibrillation and heart failure: novel insights into the chicken and egg dilemma.
     Eur Heart J. 2022 Jun 2. pii: 6599046. doi: 10.1093.
     PubMed    
     
     
     May 2022
231. JOHNSEN SP, Proietti M, Maggioni AP, Lip GYH, et al
     A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.
     Eur Heart J. 2022 May 22. pii: 6590386. doi: 10.1093.
     PubMed    
     
     
     
232. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
     Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
     Eur Heart J. 2022;43:1955-1969.
     PubMed     Abstract available
     
     
     
233. REMME CA, Leclercq C, Behr ER
     The European Cardiac Arrhythmia Genetics (ECGen) Focus Group.
     Eur Heart J. 2022;43:1891-1894.
     PubMed    
     
     
     
234. LIUZZO G, Patrono C
     A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation.
     Eur Heart J. 2022 May 13. pii: 6585115. doi: 10.1093.
     PubMed    
     
     
     
235. KANY S, Metzner A, Lubos E, Kirchhof P, et al
     The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
     Eur Heart J. 2022;43:1691-1692.
     PubMed    
     
     
     
236. CARRION-SANCHEZ I, Cobos-Gil MA
     Electrical alternans detected by an Apple Watch.
     Eur Heart J. 2022;43:1775.
     PubMed    
     
     
     April 2022
237. ODENING KE, van der Linde HJ, Ackerman MJ, Volders PGA, et al
     Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond.
     Eur Heart J. 2022 Apr 21. pii: 6571781. doi: 10.1093.
     PubMed     Abstract available
     
     
     
238. 
     Corrigendum to: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
     Eur Heart J. 2022 Apr 20. pii: 6569859. doi: 10.1093.
     PubMed    
     
     
     
239. VAN DER MEER P, Rienstra M, van Veldhuisen DJ
     A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin?
     Eur Heart J. 2022 Apr 20. pii: 6571185. doi: 10.1093.
     PubMed    
     
     
     
240. CADRIN-TOURIGNY J, Bosman LP, Nozza A, Wang W, et al
     A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
     Eur Heart J. 2022 Apr 20. pii: 6569858. doi: 10.1093.
     PubMed     Abstract available
     
     
     
241. HONG S, Kim KS, Han K, Park CY, et al
     Acromegaly and cardiovascular outcomes: a cohort study.
     Eur Heart J. 2022;43:1491-1499.
     PubMed     Abstract available
     
     
     
242. STIEGLIS R, Zijlstra JA, Riedijk F, Smeekes M, et al
     Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home.
     Eur Heart J. 2022;43:1465-1474.
     PubMed     Abstract available
     
     
     
243. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
     Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
     Eur Heart J. 2022;43:1516.
     PubMed    
     
     
     March 2022
244. SANDHU A, Varosy PD
     Left atrial appendage occlusion in patients unable to tolerate anticoagulation is cost-effective in Sweden: but how generalizable is this finding?
     Eur Heart J. 2022;43:1357-1359.
     PubMed    
     
     
     
245. SOLOMON SD, Claggett BL, Miao ZM, Diaz R, et al
     Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
     Eur Heart J. 2022 Mar 23. pii: 6552734. doi: 10.1093.
     PubMed     Abstract available
     
     
     
246. CREA F
     Novel mechanistic insights into ventricular arrhythmias and sudden death.
     Eur Heart J. 2022;43:1177-1180.
     PubMed    
     
     
     
247. CRIJNS HJGM, Sanders P, Albert CM, Lambiase PD, et al
     The year in cardiovascular medicine 2021: arrhythmias.
     Eur Heart J. 2022;43:1191-1197.
     PubMed    
     
     
     
248. CASTILHO BM, Domingues K, Damasio AF
     Pacemaker malcapture and wide QRS complexes.
     Eur Heart J. 2022;43:1272.
     PubMed    
     
     
     
249. SCHWARTZ PJ, Ackerman MJ
     Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
     Eur Heart J. 2022 Mar 18. pii: 6550339. doi: 10.1093.
     PubMed     Abstract available
     
     
     
250. SLATER NR, Murphy KR, Sikkel MB
     VT storm in long QT resulting from COVID-19 vaccine allergy treated with epinephrine.
     Eur Heart J. 2022;43:1176.
     PubMed    
     
     
     
251. MCINTYRE WF, Linz D
     Atrial fibrillation and stroke: who is low risk and what are we going to do about it?
     Eur Heart J. 2022 Mar 10. pii: 6546014. doi: 10.1093.
     PubMed    
     
     
     
252. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
     Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
     Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
     PubMed     Abstract available
     
     
     
253. PRINZEN FW, Auricchio A, Mullens W, Linde C, et al
     Electrical management of heart failure: from pathophysiology to treatment.
     Eur Heart J. 2022 Mar 10. pii: 6546052. doi: 10.1093.
     PubMed     Abstract available
     
     
     
254. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
     Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
     Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
     PubMed     Abstract available
     
     
     
255. MEHILLI J, Winhard M
     The CHADS-P2A2RC score: ready to guide the selection of treatment?
     Eur Heart J. 2022;43:1005-1007.
     PubMed    
     
     
     
256. NASSER R, Meyten N, Vermeersch P, Prihadi EA, et al
     When the solution becomes the problem: left atrial appendage occlusion device-related thrombus after 5 years.
     Eur Heart J. 2022;43:1015.
     PubMed    
     
     
     February 2022
257. KAUR H, McIntyre WF, Belley-Cote EP
     Ablate and pace for patients with atrial fibrillation: a fragile option?
     Eur Heart J. 2022 Feb 21. pii: 6533261. doi: 10.1093.
     PubMed    
     
     
     
258. JARED BUNCH T, Steinberg BA
     Clinical strokes in atrial fibrillation: the tip of the iceberg.
     Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
     PubMed    
     
     
     
259. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
     Silent brain infarcts impact on cognitive function in atrial fibrillation.
     Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
     PubMed     Abstract available
     
     
     
260. MUTAGAYWA RK, Chin A, Karaye K, Bonny A, et al
     Unmet needs in the management of arrhythmias among heart failure patients in Africa.
     Eur Heart J. 2022 Feb 15. pii: 6528559. doi: 10.1093.
     PubMed    
     
     
     
261. TAGGART P, Nash MP, Lambiase P
     Ventricular fibrillation: combined myocardial substrate and Purkinje ablation.
     Eur Heart J. 2022 Feb 9. pii: 6525334. doi: 10.1093.
     PubMed    
     
     
     
262. HAISSAGUERRE M, Cheniti G, Hocini M, Sacher F, et al
     Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation.
     Eur Heart J. 2022 Feb 3. pii: 6521660. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
263. CREA F
     Cardio-oncology: a focus on cardiovascular toxicities of cancer therapies and on atrial fibrillation in cancer.
     Eur Heart J. 2022;43:245-248.
     PubMed    
     
     
     
264. NARDUCCI ML, Volpe M
     Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
     Eur Heart J. 2022;43:261-262.
     PubMed    
     
     
     
265. NOUBIAP JJ
     The association of atrial fibrillation with mortality in patients with breast cancer.
     Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
     PubMed    
     
     
     
266. LAMBIASE PD, Theuns DA, Murgatroyd F, Barr C, et al
     Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.
     Eur Heart J. 2022 Jan 28. pii: 6516831. doi: 10.1093.
     PubMed     Abstract available
     
     
     
267. GUHA A, Alonso A, Addison D
     The association of atrial fibrillation with mortality in patients with breast cancer: author reply.
     Eur Heart J. 2022 Jan 28. pii: 6516863. doi: 10.1093.
     PubMed    
     
     
     
268. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
     Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
     Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
     PubMed     Abstract available
     
     
     
269. NICHOLLS M
     Preventing stroke in atrial fibrillation patients.
     Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
     PubMed    
     
     
     
270. 
     Corrigendum to: Incidence, Risk Factors and Mortality of Atrial Fibrillation in Breast Cancer: A SEER-Medicare Analysis.
     Eur Heart J. 2022 Jan 12. pii: 6505260. doi: 10.1093.
     PubMed    
     
     
     December 2021
271. 
     Erratum to: Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
     Eur Heart J. 2021 Dec 21. pii: 6472922. doi: 10.1093.
     PubMed    
     
     
     
272. NICHOLLS M
     Making connections to overcome arrhythmias.
     Eur Heart J. 2021;42:4878-4880.
     PubMed    
     
     
     
273. LABORI F, Persson J, Bonander C, Jood K, et al
     Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
     Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
     PubMed     Abstract available
     
     
     
274. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
     Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
     Eur Heart J. 2021 Dec 8. pii: 6456446. doi: 10.1093.
     PubMed    
     
     
     
275. CREA F
     Management of arrhythmias: the increasing role of artificial intelligence, genetics and cardiac resyncronization.
     Eur Heart J. 2021;42:4703-4706.
     PubMed    
     
     
     
276. ATTIA ZI, Harmon DM, Behr ER, Friedman PA, et al
     Application of artificial intelligence to the electrocardiogram.
     Eur Heart J. 2021;42:4717-4730.
     PubMed     Abstract available
     
     
     
277. HATALA R
     Rhythm control in asymptomatic 'early' atrial fibrillation: birth of a new paradigm?
     Eur Heart J. 2021 Dec 2. pii: 6448252. doi: 10.1093.
     PubMed    
     
     
     November 2021
278. BOR WL, Ten Berg JM
     Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
     Eur Heart J. 2021;42:4562-4564.
     PubMed    
     
     
     
279. AHLBERG G, Andreasen L, Ghouse J, Bertelsen L, et al
     Genome-wide association study identifies 18 novel loci associated with left atrial volume and function.
     Eur Heart J. 2021;42:4523-4534.
     PubMed     Abstract available
     
     
     
280. CERRONE M, Marron-Linares GM, van Opbergen CJM, Costa S, et al
     Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
     Eur Heart J. 2021 Nov 19. pii: 6431860. doi: 10.1093.
     PubMed     Abstract available
     
     
     
281. MERINO JL
     Atrial fibrillation and breast cancer: Casual or causal relationship?
     Eur Heart J. 2021 Nov 14. pii: 6427544. doi: 10.1093.
     PubMed    
     
     
     
282. GUHA A, Fradley MG, Dent SF, Weintraub NL, et al
     Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.
     Eur Heart J. 2021 Nov 14. pii: 6427396. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2021
283. HEIDBUCHEL H, Van Gelder IC, Desteghe L
     ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project.
     Eur Heart J. 2021 Oct 25. pii: 6409895. doi: 10.1093.
     PubMed    
     
     
     
284. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
     Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
     Eur Heart J. 2021 Oct 16. pii: 6398359. doi: 10.1093.
     PubMed    
     
     
     
285. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
     Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
     Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
     PubMed     Abstract available
     
     
     
286. NAGARAJAN VD, Lee SL, Robertus JL, Nienaber CA, et al
     Artificial intelligence in the diagnosis and management of arrhythmias.
     Eur Heart J. 2021;42:3904-3916.
     PubMed     Abstract available
     
     
     
287. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
     Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
     Eur Heart J. 2021;42:3932-3944.
     PubMed     Abstract available
     
     
     
288. CREA F
     The growing role of artificial intelligence and of wearable devices in the management of arrhythmias.
     Eur Heart J. 2021;42:3889-3893.
     PubMed    
     
     
     
289. GARG L, Fradley MG
     QT prolongation and cancer therapeutics: a coming Tempest or Much Ado About Nothing?
     Eur Heart J. 2021;42:3929-3931.
     PubMed    
     
     
     
290. VAN DER WERF C, Lambiase PD
     Initiation and management of polymorphic ventricular tachycardia: history gone full circle.
     Eur Heart J. 2021;42:3976-3978.
     PubMed    
     
     
     
291. ROSSO R, Hochstadt A, Viskin D, Chorin E, et al
     Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis.
     Eur Heart J. 2021;42:3965-3975.
     PubMed     Abstract available
     
     
     
292. LINDE C
     Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial.
     Eur Heart J. 2021 Oct 6. pii: 6382271. doi: 10.1093.
     PubMed    
     
     
     September 2021
293. RUSSO AM
     Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
     Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
     PubMed    
     
     
     
294. WALSH R, Adler A, Amin AS, Abiusi E, et al
     Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
     Eur Heart J. 2021 Sep 24. pii: 6374783. doi: 10.1093.
     PubMed     Abstract available
     
     
     
295. TINKER A
     Does knowledge of the mutation in hereditary long QT syndrome aid risk stratification?
     Eur Heart J. 2021 Sep 20. pii: 6372801. doi: 10.1093.
     PubMed    
     
     
     
296. CREA F
     The ESC Guidelines on cardiac pacing and resynchronization, and the many facets of atrial fibrillation.
     Eur Heart J. 2021;42:3411-3414.
     PubMed    
     
     
     
297. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
     Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrill
     Eur Heart J. 2021 Sep 14. pii: 6370283. doi: 10.1093.
     PubMed    
     
     
     
298. GLIKSON M, Nielsen JC, Kronborg MB, Michowitz Y, et al
     2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
     Eur Heart J. 2021;42:3427-3520.
     PubMed    
     
     
     
299. LIN YN, Mesquita T, Sanchez L, Chen YH, et al
     Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice.
     Eur Heart J. 2021;42:3558-3571.
     PubMed     Abstract available
     
     
     
300. SCHWARTZ PJ, Tan HL
     Long QT syndrome, artificial intelligence, and common sense.
     Eur Heart J. 2021 Sep 11. pii: 6368899. doi: 10.1093.
     PubMed    
     
     
     
301. SCHWARTZ PJ, Moreno C, Kotta MC, Pedrazzini M, et al
     Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.
     Eur Heart J. 2021 Sep 10. pii: 6368299. doi: 10.1093.
     PubMed     Abstract available
     
     
     
302. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
     Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
     Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
     PubMed     Abstract available
     
     
     
303. STEINBERG C, Krahn AD
     Quinidine vs. ICD therapy in short-coupled ventricular fibrillation-is a randomized trial the next logical step?
     Eur Heart J. 2021 Sep 4. pii: 6364089. doi: 10.1093.
     PubMed    
     
     
     
304. BELHASSEN B
     Quinidine vs. ICD in patients with short-coupled idiopathic ventricular fibrillation: a call for a multicenter randomized trial.
     Eur Heart J. 2021 Sep 4. pii: 6364083. doi: 10.1093.
     PubMed    
     
     
     
305. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
     Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
     Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
     PubMed     Abstract available
     
     
     
306. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
     Day-to-day measurement of physical activity and risk of atrial fibrillation.
     Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
     PubMed     Abstract available
     
     
     
307. PRIFTI E, Fall A, Davogustto G, Pulini A, et al
     Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome.
     Eur Heart J. 2021 Sep 1. pii: 6361017. doi: 10.1093.
     PubMed     Abstract available
     
     
     
308. ELLIOTT AD, Middeldorp ME, Linz DK
     The ins and outs of physical activity monitoring: implications for atrial fibrillation management.
     Eur Heart J. 2021 Sep 1. pii: 6361015. doi: 10.1093.
     PubMed    
     
     
     August 2021
309. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
     AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
     Eur Heart J. 2021 Aug 28. pii: 6358077. doi: 10.1093.
     PubMed     Abstract available
     
     
     
310. CURTAIN JP, Docherty KF, Jhund PS, Petrie MC, et al
     Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
     Eur Heart J. 2021 Aug 27. pii: 6358075. doi: 10.1093.
     PubMed     Abstract available
     
     
     
311. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
     Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
     Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
     PubMed     Abstract available
     
     
     
312. LIGHT PE
     Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure.
     Eur Heart J. 2021 Aug 27. pii: 6358226. doi: 10.1093.
     PubMed    
     
     
     
313. CHIANG PH, Hsu YC, Wei JC
     Methodological considerations when discussing the fracture risk of atrial fibrillation patients taking different drug.
     Eur Heart J. 2021 Aug 11. pii: 6348063. doi: 10.1093.
     PubMed    
     
     
     
314. HUANG HK, Tu YK, Loh CH
     Fracture risk associated with different oral anticoagulants in patients with atrial fibrillation: updated evidence from real-world observational studies and clinical trials.
     Eur Heart J. 2021 Aug 11. pii: 6348060. doi: 10.1093.
     PubMed    
     
     
     
315. WANG N, Sun Y, Zhang H, Wang B, et al
     Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.
     Eur Heart J. 2021 Aug 10. pii: 6347324. doi: 10.1093.
     PubMed     Abstract available
     
     
     
316. SALEM JE, Nguyen LS, Moslehi JJ, Ederhy S, et al
     Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
     Eur Heart J. 2021 Aug 9. pii: 6346756. doi: 10.1093.
     PubMed     Abstract available
     
     
     
317. NICHOLLS M
     Reflections on EHRA 2021.
     Eur Heart J. 2021;42:2880-2881.
     PubMed    
     
     
     
318. RASMUSSEN PV, Hylek E
     Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants.
     Eur Heart J. 2021 Aug 4. pii: 6339772. doi: 10.1093.
     PubMed    
     
     
     
319. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
     Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
     Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
     PubMed     Abstract available
     
     
     
320. REIFFEL JA
     When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
     Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
     PubMed    
     
     
     July 2021
321. WILDE AAM, Wu CI
     Does function trump bioinformatics in Brugada syndrome-associated SCN5A mutation calling? Patients, computers, and patches.
     Eur Heart J. 2021;42:2864-2865.
     PubMed    
     
     
     
322. ISHIKAWA T, Kimoto H, Mishima H, Yamagata K, et al
     Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
     Eur Heart J. 2021;42:2854-2863.
     PubMed     Abstract available
     
     
     
323. ALHUMAID W, Yogasundaram H, Senaratne JM
     Slow bidirectional ventricular tachycardia as a manifestation of immune checkpoint inhibitor myocarditis.
     Eur Heart J. 2021;42:2868.
     PubMed    
     
     
     
324. GUASCH E, Nattel S
     Ageing, comorbidities, and the complex determinants of atrial fibrillation in athletes.
     Eur Heart J. 2021 Jul 23. pii: 6327053. doi: 10.1093.
     PubMed    
     
     
     
325. ADABAG S, Madjid M, Cheng A
     An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic.
     Eur Heart J. 2021 Jul 19. pii: 6323687. doi: 10.1093.
     PubMed    
     
     
     
326. 
     Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.
     Eur Heart J. 2021 Jul 16. pii: 6322394. doi: 10.1093.
     PubMed    
     
     
     
327. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
     Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
     Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
     PubMed     Abstract available
     
     
     
328. BUNTING KV, Stanbury M, Tica O, Kotecha D, et al
     Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial.
     Eur Heart J. 2021;42:2411-2414.
     PubMed    
     
     
     June 2021
329. 
     Erratum to: Alcohol Consumption, Cardiac Biomarkers and Risk of Atrial Fibrillation and Adverse Outcomes.
     Eur Heart J. 2021 Jun 30. pii: 6311430. doi: 10.1093.
     PubMed    
     
     
     
330. VAN DER REE MH, Postema PG
     What's in a name? further classification of patients with apparent idiopathic ventricular fibrillation.
     Eur Heart J. 2021 Jun 21. pii: 6306957. doi: 10.1093.
     PubMed    
     
     
     
331. SCHNABEL RB, Fabritz L, Kirchhof P
     Mobile health for walking on the tightrope of optimal physical activity to reduce the risk of atrial fibrillation.
     Eur Heart J. 2021 Jun 20. pii: 6306826. doi: 10.1093.
     PubMed    
     
     
     
332. 
     Corrigendum to: A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
     Eur Heart J. 2021 Jun 16. pii: 6300115. doi: 10.1093.
     PubMed    
     
     
     
333. VERSTRAELEN TE, van Lint FHM, Bosman LP, de Brouwer R, et al
     Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
     Eur Heart J. 2021 Jun 11. pii: 6296140. doi: 10.1093.
     PubMed     Abstract available
     
     
     
334. LEE SR, Choi EK, Jung JH, Han KD, et al
     Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
     Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2021
335. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
     Accelerometer-derived physical activity and risk of atrial fibrillation.
     Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
     PubMed     Abstract available
     
     
     
336. PARK S, Lee S, Kim Y, Lee Y, et al
     Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
     Eur Heart J. 2021 May 23. pii: 6282432. doi: 10.1093.
     PubMed     Abstract available
     
     
     
337. BENN M
     Atrial Fibrillation And Chronic Kidney Disease.
     Eur Heart J. 2021 May 23. pii: 6282434. doi: 10.1093.
     PubMed    
     
     
     
338. TOMSITS P, Clauss S, Kaab S
     Genetic insight into sick sinus syndrome. Is there a pill for it or how far are we on the translational road to personalized medicine?
     Eur Heart J. 2021;42:1972-1975.
     PubMed    
     
     
     
339. MARSTON NA, Han L, Olivotto I, Day SM, et al
     Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
     Eur Heart J. 2021;42:1988-1996.
     PubMed     Abstract available
     
     
     
340. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
     Genetic insight into sick sinus syndrome.
     Eur Heart J. 2021;42:1959-1971.
     PubMed     Abstract available
     
     
     
341. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
     Genetic insight into sick sinus syndrome.
     Eur Heart J. 2021;42:1959-1971.
     PubMed     Abstract available
     
     
     
342. STEINBERG C, Davies B, Mellor G, Tadros R, et al
     Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
     Eur Heart J. 2021 May 19. pii: 6278425. doi: 10.1093.
     PubMed     Abstract available
     
     
     
343. CSENGERI D, Sprunker NA, Schnabel RB
     Alcohol and atrial fibrillation: dose matters, not so much the type.
     Eur Heart J. 2021 May 9. pii: 6272848. doi: 10.1093.
     PubMed    
     
     
     
344. MESSERLI FH, Dobner S
     Alcohol and atrial fibrillation: not all drinks are created equal.
     Eur Heart J. 2021 May 8. pii: 6272093. doi: 10.1093.
     PubMed    
     
     
     
345. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
     What do we learn by repeating the ABC?
     Eur Heart J. 2021;42:1707-1709.
     PubMed    
     
     
     
346. GNECCHI M, Sala L, Schwartz PJ
     Precision Medicine and cardiac channelopathies: when dreams meet reality.
     Eur Heart J. 2021;42:1661-1675.
     PubMed     Abstract available
     
     
     
347. DELISE P
     Risk stratification in Brugada syndrome: the challenge of the grey zone.
     Eur Heart J. 2021;42:1696-1697.
     PubMed    
     
     
     
348. PROBST V, Goronflot T, Anys S, Tixier R, et al
     Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome.
     Eur Heart J. 2021;42:1687-1695.
     PubMed     Abstract available
     
     
     
349. MINOIS D, Sellal JM, Magnin I, de Chillou C, et al
     Left ventricular diverticulum associated with two concealed atrioventricular accessory pathways.
     Eur Heart J. 2021;42:1714.
     PubMed    
     
     
     April 2021
350. GALIUTO L, Volpe M
     Cryoblation as first-line treatment of new-onset atrial fibrillation?
     Eur Heart J. 2021;42:1543-1544.
     PubMed    
     
     
     
351. SMOLDEREN KG, Burg MM
     A broken heart after child loss.
     Eur Heart J. 2021;42:1496-1498.
     PubMed    
     
     
     
352. BRIEGER D, Freedman B
     Decoding stroke risk scores in atrial fibrillation: still more work to do.
     Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
     PubMed    
     
     
     March 2021
353. EL-BATTRAWY I, Lang S, Zhou X, Akin I, et al
     Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
     Eur Heart J. 2021;42:1270-1272.
     PubMed    
     
     
     
354. PAPPONE C, Ciconte G, Micaglio E, Monasky MM, et al
     Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
     Eur Heart J. 2021;42:1273-1274.
     PubMed    
     
     
     
355. YOUNIS A, Goldenberg I
     Extending the MADIT-ICD benefit score to heterogenous heart failure populations.
     Eur Heart J. 2021 Mar 18. pii: 6177051. doi: 10.1093.
     PubMed    
     
     
     
356. POSTEMA PG, Walsh R, Bezzina CR
     Illuminating the path from genetics to clinical outcome in Brugada syndrome.
     Eur Heart J. 2021;42:1091-1093.
     PubMed    
     
     
     
357. BEHR ER, Ben-Haim Y, Ackerman MJ, Krahn AD, et al
     Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
     Eur Heart J. 2021;42:1073-1081.
     PubMed     Abstract available
     
     
     
358. CICONTE G, Monasky MM, Santinelli V, Micaglio E, et al
     Brugada syndrome genetics is associated with phenotype severity.
     Eur Heart J. 2021;42:1082-1090.
     PubMed     Abstract available
     
     
     
359. IRIART X, Metras A, Coiffic A, Thambo JB, et al
     Late device-related thrombus after left atrial appendage closure: never let your guard down.
     Eur Heart J. 2021;42:1050.
     PubMed    
     
     
     February 2021
360. SAWANO S, Nakayama A, Morita H, Komuro I, et al
     Rathke's cleft cyst induced cardiac arrest.
     Eur Heart J. 2021;42:714.
     PubMed    
     
     
     
361. CRIJNS HJGM, Prinzen F, Lambiase PD, Sanders P, et al
     The year in cardiovascular medicine 2020: arrhythmias.
     Eur Heart J. 2021;42:499-507.
     PubMed     Abstract available
     
     
     
362. SCHNEEWEIS C, Ahrens I, Saygili E, Steven D, et al
     Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation.
     Eur Heart J. 2021;42:544.
     PubMed    
     
     
     January 2021
363. KITE TA, Gershlick AH
     High-risk NSTE-ACS: high time for robust data.
     Eur Heart J. 2021;42:352.
     PubMed    
     
     
     
364. HAMILTON GW, Lim HS
     Ventricular tachycardia vs. supraventricular tachycardia with aberrancy.
     Eur Heart J. 2021;42:133.
     PubMed    
     
     
     December 2020
365. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
     Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
     Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
     PubMed     Abstract available
     
     
     
366. WILDE AAM, Lodder EM
     Biomarkers in inherited arrhythmias: necessity for validation and collaboration.
     Eur Heart J. 2020;41:4523-4524.
     PubMed    
     
     
     
367. HAMILTON RM, Chatterjee D, Saguner AM
     Biomarkers in inherited arrhythmias: opportunities for validation and collaboration.
     Eur Heart J. 2020;41:4521-4522.
     PubMed    
     
     
     November 2020
368. VERHAMME P, Budts W, Van de Werf F
     Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?
     Eur Heart J. 2020;41:4178-4180.
     PubMed    
     
     
     April 2020
369. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
     Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
     Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2020
370. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
     Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
     Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2019
371. LANCINI D, Shetty R
     Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
     Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
     PubMed    
     
     
     
372. KALLA M, Hao G, Tapoulal N, Tomek J, et al
     The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
     Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2019
373. PACKER M
     What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
     Eur Heart J. 2019 Aug 7. pii: 5544750. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2019
374. REDDY YNV, Borlaug BA, O'Connor CM, Gersh BJ, et al
     Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.
     Eur Heart J. 2019 Jun 14. pii: 5519089. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.